GlassScriptPhysician profile
Pamela Bergeron
NPI 1235314063
$1,568.07
in general payments reported to CMS, 2019-2025
18 companies · $292 in 2025
The $292 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $326 · 2022: $414 · 2023: $307 · 2024: $229 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $279.56 | 2021-2025 | Veozah |
| Abbvie INC. | $269.91 | 2022-2023 | |
| Daiichi Sankyo INC. | $165.51 | 2021-2024 | Injectafer |
| Organon LLC | $148.47 | 2021-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $148.43 | 2023-2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $131.28 | 2021-2022 | |
| Acessa Health INC. | $80.83 | 2021 | |
| Coopersurgical, INC. | $63.32 | 2022 | |
| Lilly USA, LLC | $40.73 | 2021-2024 | Zepbound |
| Merck Sharp & Dohme LLC | $38.47 | 2021-2025 | Gardasil 9, M-M-R II |
| Pfizer INC. | $36.53 | 2021-2022 | |
| Baxter Healthcare | $34.93 | 2022-2023 | Perclot |
| Abbott Laboratories | $34.27 | 2023-2024 | Proclaim |
| Evofem Biosciences, INC. | $28.21 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $22.62 | 2025 | Exparel |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $17.24 | 2021 | |
| Avion Pharmaceuticals | $14.28 | 2022 | |
| Therapeuticsmd, INC. | $13.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Bergeron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.